Barclays
LENS

Barclays’s Presbia PLC Ordinary Shares LENS Stock Holding History

Barclays’s Portfolio LENS Stock Details LENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-59
Closed – – 7686
2018
Q1 		$0 Buy
+59
New +$185 ﹤0.01% 7681

Other funds holding LENS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays's LENS Position: Q2 2018 in Review

Barclays sold out of Presbia PLC Ordinary Shares (LENS) in Q2 2018, closing a stake of 59 shares.

Barclays first reported a position in LENS in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 10 funds tracked by Wall St. Rank hold LENS as of Q2 2018.

  • Barclays reported no remaining Presbia PLC Ordinary Shares position as of Q2 2018 after selling out during the quarter.
  • Barclays sold 59 Presbia PLC Ordinary Shares shares in Q2 2018.
  • Barclays first reported a position in Presbia PLC Ordinary Shares in Q1 2018 and held it in 1 quarter.
  • Barclays's Presbia PLC Ordinary Shares position peaked at $0 in Q1 2018.
  • 10 funds tracked by Wall St. Rank held Presbia PLC Ordinary Shares as of Q2 2018.

Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.